Sleep and immunity: A growing field with clinical impact

Brain, Behavior, and Immunity

Volumn 47, Issue , 2015, Pages 1-3

  Opp, Mark R ^a   Krueger, James M ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; TUMOR NECROSIS FACTOR;

CYTOKINE PRODUCTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; IMMUNOREGULATION; LYMPHOCYTE; NONHUMAN; NOTE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SLEEP; SLEEP DEPRIVATION; SLEEP TIME; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; PHYSIOLOGY; SLEEP DISORDER;

HUMANS; IMMUNE SYSTEM; SLEEP; SLEEP WAKE DISORDERS;

EID: 84930751933     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.03.011     Document Type: Note

References (56)

1. Ayas N.T., White D.P., Manson J.E., Stampfer M.J., Speizer F.E., Malhotra A., Hu F.B. A prospective study of sleep duration and coronary heart disease in women. Arch. Intern. Med. 2003, 163:205-209.
2. Cappuccio F.P., Cooper D., D'elia L., Strazzullo P., Miller M.A. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur. Heart J. 2011, 32:1484-1492.
3. Chen J., Buchanan J.B., Sparkman N.L., Godbout J.P., Freund G.G., Johnson R.W. Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav. Immun. 2008, 22:301-311.
4. Dinges D.F., Douglas S.D., Zaugg L., Campbell D.E., Mcmann J.M., Whitehouse W.G., Orne E.C., Kapoor S.C., Icaza E., Orne M.T. Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation. J. Clin. Invest. 1994, 93:1930-1939.
5. Flynn-Evans E.E., Mucci L., Stevens R.G., Lockley S.W. Shiftwork and prostate-specific antigen in the national health and nutrition examination survey. J. Natl. Cancer Inst. 2013, 105:1292-1297.
6. Gangwisch J.E., Heymsfield S.B., Boden-Albala B., Buijs R.M., Kreier F., Pickering T.G., Rundle A.G., Zammit G.K., Malaspina D. Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep 2007, 30:1667-1673.
7. Gay C.L., Zak R.S., Lerdal A., Pullinger C.R., Aouizerat B.E., Lee K.A. Cytokine polymorphisms and plasma levels are associated with sleep onset insomnia in adults living with HIV/aids. Brain Behav. Immun. 2015, 47:58-65.
8. Haack M., Pollmacher T., Mullington J.M. Diurnal and sleep-wake dependent variations of soluble Tnf- and Il-2 receptors in healthy volunteers. Brain Behav. Immun. 2004, 18:361-367.
9. Haack M., Sanchez E., Mullington J.M. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 2007, 30:1145-1152.
10. Haubrich D.R., Perez-Cruet J., Reid W.D. Prostaglandin E1 causes sedation and increases 5-hydroxytryptamine turnover in rat brain. Br. J. Pharmacol. 1973, 48:80-87.
11. Honda K., Komoda Y., Nishida S., Nagasaki H., Higashi A., Uchizono K., Inoue S. Uridine as an active component of sleep-promoting substance: its effects on nocturnal sleep in rats. Neurosci. Res. 1984, 1:243-252.
12. Irwin M. Effects of sleep and sleep loss on immunity and cytokines. Brain Behav. Immun. 2002, 16:503-512.
13. Irwin M.R., Carrillo C., Olmstead R. Sleep loss activates cellular markers of inflammation: sex differences. Brain Behav. Immun. 2010, 24:54-57.
14. Irwin M.R., Wang M., Campomayor C.O., Collado-Hidalgo A., Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch. Intern. Med. 2006, 166:1756-1762.
15. Ishimori K. True cause of sleep: a hypnogenic substance as evidenced in the brain of sleep-deprived animals. Tokyo Igakkai Zasshi 1909, 23:429-459.
16. Kakizaki M., Kuriyama S., Sone T., Ohmori-Matsuda K., Hozawa A., Nakaya N., Fukudo S., Tsuji I. Sleep duration and the risk of breast cancer: the Ohsaki cohort study. Br. J. Cancer 2008, 99:1502-1505.
17. Knutsson A., Kempe A. Shift work and diabetes-a systematic review. Chronobiol. Int. 2014, 31:1146-1151.
18. Krueger J.M. The role of cytokines in sleep regulation. Curr. Pharm. Des. 2008, 14:3408-3416.
19. Krueger J.M., Dinarello C.A., Chedid L. Promotion of slow-wave sleep (SWS) by a purified interleukin-1 (Il-1) preparation. Fed. Proc. 1983, 42:356.
20. Krueger J.M., Pappenheimer J.R., Karnovsky M.L. Sleep-promoting effects of muramyl peptides. Proc. Natl. Acad. Sci. U.S.A. 1982, 79:6102-6106.
21. Laychock S.G., Johnson D.N., Harris L.S. Pgd2 effects on rodent behavior and eeg patterns in cats. Pharmacol. Biochem. Behav. 1980, 12:747-754.
22. Legendre R., Piéron H. Le Problème Des Facteurs Du Sommeil. Résultats D'injections Vasculaires Et Intracérébrales De Liquides Insomniques. C. R. Soc. Biol. 1910, 68:1077-1079.
23. Legendre R., Piéron H. Recherches Sur Le Besoin De Sommeil Consecutif A Une Vielle Prolongee. Z. Allg. Physiol. 1913, 14:235-262.
24. Lekander M., Andreasson A.N., Kecklund G., Ekman R., Ingre M., Akerstedt T., Axelsson J. Subjective health perception in healthy young men changes in response to experimentally restricted sleep and subsequent recovery sleep. Brain Behav. Immun. 2013, 34:43-46.
25. Leproult R., Holmback U., Van C.E. Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes 2014, 63:1860-1869.
26. Liu Y., Wheaton A.G., Chapman D.P., Croft J.B. Sleep duration and chronic diseases among U.S. adults age 45 years and older: evidence from the 2010 behavioral risk factor surveillance system. Sleep 2013, 36:1421-1427.
27. Mallon L., Broman J.E., Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care 2005, 28:2762-2767.
28. Meier-Ewert H.K., Ridker P.M., Rifai N., Regan M.M., Price N.J., Dinges D.F., Mullington J.M. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J. Am. Coll. Cardiol. 2004, 43:678-683.
29. Meisinger C., Heier M., Lowel H., Schneider A., Doring A. Sleep duration and sleep complaints and risk of myocardial infarction in middle-aged men and women from the general population: the MONICA/KORA Augsburg cohort study. Sleep 2007, 30:1121-1127.
30. Monk T.H., Buysse D.J. Exposure to shift work as a risk factor for diabetes. J. Biol. Rhythms 2013, 28:356-359.
31. Mullington J.M., Haack M., Toth M., Serrador J., Meier-Ewert H.K. Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog. Cardiovasc. Dis. 2009, 51:294-302.
32. Mullington J.M., Simpson N.S., Meier-Ewert H.K., Haack M. Sleep loss and inflammation. Best Pract. Res. Clin. Endocrinol. Metab. 2010, 24:775-784.
33. Norman S.E., Chediak A.D., Freeman C., Kiel M., Mendez A., Duncan R., Simoneau J., Nolan B. Sleep disturbances in men with asymptomatic human immunodeficiency (HIV) infection. Sleep 1992, 15:150-155.
34. Norman S.E., Chediak A.D., Kiel M., Cohn M.A. Sleep disturbances in HIV infected homosexual men. Aids 1990, 4:775-781.
35. Norman S.E., Resnik L., Cohn M.A., Duara R., Herbst J., Berger J.R. Sleep disturbances in HIV-seropositive patients. Jama 1988, 260:922.
36. Opp M.R. Cytokines and sleep: the first hundred years. Brain Behav. Immun. 2004, 18:295-297.
37. Opp M.R. Cytokines and sleep. Sleep Med. Rev. 2005, 9:355-364.
38. Opp M.R. Sleeping to fuel the immune system: mammalian sleep and resistance to parasites. BMC Evol. Biol. 2009, 9:8.
39. Opp M., Born J., Irwin M. Sleep and the immune system. Psychoneuroimmunology 2007, 579-618. Elseveir Academic Press, Burlington, MA. R. Ader (Ed.).
40. Palmblad J., Pertrini B., Wasserman J., Kerstedt T.A. Lymphocyte and granulocyte reactions during sleep deprivation. Psychosom. Med. 1979, 41:273-278.
41. Phillips D.J., Savenkova M.I., Karatsoreos I.N. Environmental disruption of the circadian clock leads to altered sleep and immune responses in mouse. Brain Behav. Immun. 2015, 47:14-23.
42. Preston B.T., Capellini I., Mcnamara P., Barton R.A., Nunn C.L. Parasite resistance and the adaptive significance of sleep. BMC Evol. Biol. 2009, 9:7.
43. Rabstein S., Harth V., Justenhoven C., Pesch B., Plottner S., Heinze E., Lotz A., Baisch C., Schiffermann M., Brauch H., Hamann U., Ko Y., Bruning T. Polymorphisms in circadian genes, night work and breast cancer: results from the Genica study. Chronobiol. Int. 2014, 31:1115-1122.
44. Radulovacki M., Miletich R.S., Green R.D. N6 (L-phenylisopropyl) adenosine (L-p ha) increases slow-wave sleep (S2) and decreases wakefulness in rats. Brain Res. 1982, 246:178-180.
45. Sachs J., Unger J., Waser P.G., Borbély A.A. Factors in cerebrospinal fluid affecting motor activity in the rat. Neurosci. Lett. 1976, 2:83-86.
46. Schnedorf J.G., Ivy A.C. An examination of the hypnotoxin theory of sleep. Am. J. Physiol. Legacy Content 1939, 125:491-505.
47. Schoenenberger G.A., Maier P.F., Tobler H.J., Monnier M. A naturally occurring delta-eeg enhancing nonapeptide in rabbits. Pflügers Archiv-Eur. J. Physiol. 1977, 369:99-109.
48. Sigurdardottir L.G., Valdimarsdottir U.A., Mucci L.A., Fall K., Rider J.R., Schernhammer E., Czeisler C.A., Launer L., Harris T., Stampfer M.J., Gudnason V., Lockley S.W. Sleep disruption among older men and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 2013, 22:872-879.
49. Simpson N., Dinges D.F. Sleep and inflammation. Nutr. Rev. 2007, 65:S244-S252.
50. Toth L.A. Microbial modulation of sleep. Handbook of behavioral state control: cellular and molecular mechanisms 1999, 641-657. Crc Press, Boca Raton. R. Lydic, H.A. Baghdoyan (Eds.).
51. Toth L.A., Opp M.R. Infection and sleep. Sleep medicine 2002, 77-84. Hanley & Belfus Inc, Philadelphia. T. Lee-Chiong, M.A. Carskadon, M. Sateia (Eds.).
52. Toth L.A., Tolley E.A., Krueger J.M. Sleep as a prognostic indicator during infectious disease in rabbits. Proc. Soc. Exp. Biol. Med. 1993, 203:179-192.
53. Ueno R., Ishikawa Y., Nakayama T., Hayaishi O. Prostaglandin D2 induces sleep when microinjected into the preoptic area of conscious rats. Biochem. Biophys. Res. Commun. 1982, 109:576-582.
54. Von Ruesten A., Weikert C., Fietze I., Boeing H. Association of sleep duration with chronic diseases in the european prospective investigation into cancer and Nutrition (Epic)-potsdam study. PLoS ONE 2012, 7:E30972.
55. Wright K.P., Drake A.L., Frey D.J., Fleshner M., Desouza C.A., Gronfier C., Czeisler C.A. Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance. Brain Behav. Immun. 2015, 47:24-34.
56. Zielinski M.R., Krueger J.M. Sleep and innate immunity. Front Biosci. (Schol. Ed) 2011, 3:632-642.